Abstract-In order to elucidate the biological role of T-kininogen, it's levels in plasma, exudate, and liver were measured by radioimmunoassay in rats following the induction of carrageenin pleurisy. T-kininogen level in the liver microsomes was increased markedly at 8-24 hr after the carrageenin injection, and its plasma level increased at 24-48 hr with a delay. Pretreatment with dexamethasone suppressed the pleural exudate accumulation almost completely, but inhibited the T-kininogen level in plasma or liver only partially. When rats were pretreated with carrageenin injection into a paw 2 days prior to intrapleural injection of carrageenin, the pretreat ment did not affect the pleurisy development, even though the plasma level of T kininogen was greatly increased. Increased level of T-kininogen correlated well with the thiol protease inhibitor activity found in the plasma and exudate. These results indicate that an increase in the T-kininogen level does not influence the exudation, but might act as an inhibitor of thiol proteases that could be released at the inflammatory site.
T-kininogen has a bradykinin moiety and thiol protease inhibitor region in its primary structure (1) (2) (3) . It was reported to be an acute phase reactant in rats and its plasma level in creases after inflammatory stimuli and lesion (4) (5) (6) (7) . Among these studies, Barlas et al. reported that plasma T-kininogen level was increased in parallel with paw swelling fol lowing Freund's adjuvant treatment (7). Our previous experiments demonstrated that T kininogen was found in the plasma of HMW and LMW-kininogens deficient rats (Brown Norway Katholiek strain) and that the level was increased after turpentine and car rageenin injection in a similar manner as in normal strain animals (6). However, the deficient strain showed less reactivity to carrageenin-induced inflammation. There fore we assumed that HMW-kininogen was responsible for the inflammatory reaction, but T-kinninogen was not involved. The present study was undertaken to determine whether T-kininogen works as an anti-inflammatory or pro-inflammatory agent when it's level is increased by inflammatory stimuli. For its quantification, we measured T-kininogen by a specific radioimmunoassay that we had pre viously developed (8).
Materials and Methods Induction of pleurisy: Male 7-week-old Sprague-Dawley rats were purchased from Shizuoka Experimental Animal Center (Hamamatsu).
The series of experiments on rat pleurisy were done as previously reported (9). Pleurisy was induced by the intrapleural injection of 0.1 ml of 2% carrageenin (Sigma). When used, dexamethasone (Sigma) was dissolved in ethyl alcohol (10 mg/0.5 ml), diluted in physiological saline (0.5 mg/ml), and then injected intraperitoneally into rats 2 hr prior to the carrageenin injection. Con trol rats received vehicle only and were otherwise treated in the same manner.
Measurement of T-kininogen and protein content: T-kininogen contents in the plasma, and liver microsomal fraction were measured by a specific radioimmunoassay using monoclonal antibody to T-kininogen as pre viously described (8, 10 Liver microsomal fraction preparation and assay: The livers were perfused with ap proximately 15 ml of Tyrode's solution through the portal vein and homogenized as previously reported (7). T-kininogen content was assayed by RIA (8).
Thiol protease inhibitor activity: Papain (Sigma), 25 ng, was preincubated at 30°C for 10 min in 1 m! of 0.4 M sodium acetate buffer, pH 7.5, containing 4 mM EDTA-2Na, 0.01% gelatin and 1 mM cysteine; and then rat plasma or exudate was added, and the mixture was incubated at 37°C for 10 min. The remaining thiol protease activity was then assessed by the production of fluorescence after incubation with Z-phe-arg-MCA (Pep tide Institute, Minoh) (14).
Elimination of T-kininogen in blood: 1251 T-kininogen (1 icg, 106 cpm) was injected into the tail vein of rats, and a blood sample was collected from the brachial vein or tail vein under light ether anesthesia at the indicated time. The half life of each elimi nation curve was calculated using the two compartment model. Statistical analysis: Statistical analyses were carried out by Student's t-test at P<_ 0.05 or P<0.01.
Results
Time course of rat pleurisy and T-kininogen levels: Figure 1 shows the time course of carrageenin induced rat pleurisy. As shown in panel A, pleural fluid accumulation peaked at 16 hr after the carrageenin injection, and it gradually decreased until the value was around 1 ml at 96 hr. Leukocyte migration into the exudate took place later than the exudate formation, and the peak was observed at 24 hr. Classification of leukocytes indicated that PMN leukocytes migrated earlier, and then later, monocytes increased in number in the exudate. Figure 2 indicates T-kininogen levels in the plasma, exudate, and liver during the pleurisy.
The level in the plasma slowly increased up to 24 hr after carrageenin injection, and the peak level was about 6-7 fold over the control level. By 96 hr, the level had decreased, but was still 3 times higher than the control level. The T-kininogen level in the pleural exudate also increased, with kinetics similar to but slightly slower than that in plasma. Protein concentration in the pleural fluid increased rapidly at 3-8 hr and then stayed almost con stant. The level in the liver increased slightly faster than the level in plasma, indicating that the synthesis may take place in the liver following the inflammatory stimulus.
Effect of pretreatment with dexamethasone: Dexamethasone at a dose of 0.5 mg/kg was injected intraperitoneally 2 hr before the car rageenin.
Pleurisy at 16 hr after the car rageenin was examined as illustrated in Fig. 3 . The accumulation of pleural fluid was com pletely suppressed and cell migration was significantly decreased. T-kininogen levels in the plasma and liver were significantly but not completely decreased by the pretreatment.
Effect of pretreatment with carrageenin: This experiment was undertaken to see if the increased T-kininogen level would affect the development of pleurisy. T-kininogen plasma level was increased following the carrageenin injection at the paw, and it was 13±2 and 11 ±1 (,ug/mg protein with standard error) at 48 hr and 72 hr, respectively. Then the level increased further after the second injection of carrageenin: about 27 and 50 #g/mg of CG+CG 3h and CG+CG 16h, respectively, in Fig. 4 . As shown in Fig. 4 , pretreatment with 1 % carrageenin (0.1 ml into a paw 2 days before the pleural injection of carrageenin) had no significant effect on pleural fluid ac cumulation or on leukocyte counts in the exudates at 3 hr and 16 hr.
Effect of pretreatment with bromelain: Bromelain injection into rats was previously reported to deplete HMW-kininogen and to decrease carrageenin pleurisy at 3 hr (15). The treatment decreased exudation signifi cantly even at 16 hr of pleurisy, but the T kininogen level increased after carrageenin injection with or without bromelain pretreat ment (Fig. 5) .
Elimination of T-kininogen from rat plasma: Elimination of 1251-T-kininogen from plasma was examined in normal and inflamed rats. The latter rats received intrapleural car rageenin 16 hr before the sample collection. The half lives of 1251-T-kininogen levels in plasma with standard errors were 27.5±1.1 hr (n=4) for normal rats and 26.7+1.4 (n=4) hr for the inflamed ones.
Thiol protease inhibitor activity: Thiol protease-inhibiting activity of the plasma and of the inflammatory exudate of these pleurisies were measured by the remaining amidase activity of papain. Figure 6 shows the relationships of T-kininogen level in plasma (A) and pleural exudate (B) to the inhibitor activity. All data of pleurisy at 3 hr to 16 hr were plotted. Correlation coefficients of the inhibitory activity against T-kininogen levels of plasma and of the exudate were 0.96 and 0.88, at P----0.06, with slopes of 0.48 and 0.39, respectively.
Discussion
The time course of carrageenin-induced pleurisy was mostly similar to that reported by Uchida et al. (16). As reported previously (8, 10), the increased T-kininogen level in plasma of rats receiving inflammatory stimuli could be caused by increased synthesis of this protein in the liver, since the liver level increased faster than the plasma level, as shown in Fig. 2 . Plasma elimination of T kininogen in inflamed rats was not signifi Rats were divided into 5 groups and numbers of rats used are shown by the figures by the columns in panel (A): a, untreated control group; b, group receiving intraperitoneal vehicle injection (2 .5% ethanol, 1 ml/kg) at 18 hr before the sacrifice; c, group receiving intraperitoneal dexamethasone in 2 .5% ethanol, 0.5 mg/kg, at 18 hr before the sacrifice; d, group sacrificed at 1 6 hr after intrapleural injection of 0.1 ml of 2% carrageenin solution which was preceded 2 hr earlier by an injection of 2.5% ethanol as a vehicle; e, group sacrificed at 16 hr after the carrageenin injection which was preceded 2 hr earlier by an intraperitoneal injection of 0.5 mg/kg dexamethasone. Fig. 4 . Effect of pretreatment with carrageenin on the development of pleurisy and T-kininogen levels. Panels (A) to (F) indicate the same parameters examined as those in Fig. 3 . Rats are in 5 groups, and numbers used are shown at the tops of the columns in panel (A). Group a, untreated control; b, sacrificed at 3 hr of carrageenin pleurisy without pretreatment; c, carrageenin pleurisy at 3 hr with pretreatment of intradermal carrageenin injection into a paw 2 days before the initiation of pleurisy; d, carrageenin pleurisy at 16 hr without pretreatment; and e, carrageenin pleurisy at 16 hr with the pretreatment of intradermal carrageenin injected into a paw 2 days prior to the initiation of the pleurisy.
partly decreased the T-kininogen levels in the plasma and liver, as shown in Fig. 3 . Barlas et al. reported that inhibitory effects of dexamethasone and indomethacin on paw swelling induced by the adjuvant was parallel with the reduction of T-kininogen level (7). This was not the case in our studies, and we have to consider multiple actions of dexame thasone on the defense reaction. One of the anti-inflammatory effects of dexamethasone is known to be its production of anti-phos pholipase protein to suppress arachidonate metabolites production (17). Another mode of action of dexamethasone may cause a partial suppression of T-kininogen level by inhibiting the production of cytokine which has been suggested to be a mediator for he patic induction of T-kininogen synthesis (18). We tried to determine if an increased T kininogen level might work as an anti-inflam matory agent, since some counter irritants have been used for treatment of inflammation (19). As shown in Fig. 2 , pretreatment with inflammatory stimuli such as carrageenin caused a marked increase in T-kininogen level. However, the increased level of T kininogen does not appear to cause sup pression of pleural exudation, since no inhibition was observed with carrageenin pretreatment up to 16 hr (Fig. 4) . Therefore the increased level of T-kininogen does not directly account for the counter irritant effect. Furthermore, the pretreatment with bromelain resulted in marked suppression of exudation at 16 hr in the same way as that at 3 hr, which was previously reported (15). However, bromelain pretreatment did not have any significant effect on the increased level of T kininogen after carrageenin injection. In other words, the plasma T-kininogen level of carrageenin-treated rats and rats pretreated with bromelain were similar, while the former animals showed marked pleural exudation, and the latter had less exudate formation. These results coincide well with those given in our previous report, in which the time course of paw edema swelling preceded the increase in T-kininogen level, thus leading us to con clude that T-kininogen played no role in exudation; i.e., it was not involved in either proinflammatory or anti-inflammatory action (9). Kininogen are reported to possess thiol protease inhibitory activity (14) since the binding sites for thiol proteases have been demonstrated in their sequences (20). There fore we can expect that T-kininogen might work to inhibit enzymes involved in inflamma tory process. Figure 6 demonstrates clearly that the inhibitory activity against papain increased linearly with the content of T kininogen in plasma or exudate. Thus a close relationship exists between the inhibitory ac tivity and T-kininogen level. Furthermore, the slope of the activity in the exudate showed a slight decay, indicating that T-kininogen in the exudate is less active; i.e., a part of the T-kininogen in the exudate might be bound or degraded by an enzyme(s) in the exudate. Our result could not show any direct evidence for the anti-inflammatory character of T kininogen even with its potent protease in hibitory effect. However, it may affect later defense mechanisms of body such as the immune activity, etc. Elucidation of this relationship remains for a future study.
